Researchers have substantially improved this course of a new treatment for cardiac amyloidosis, leveraging the investigational drug. Early patient information suggests significant outcomes for individuals suffering from a severe condition. The focus underscores the company’s focus to addressing unmet healthcare needs in a heart arena. A… Read More